Therabron Therapeutics to Present at BioCentury 23rd Annual Future Leaders in the Biotech Industry Conference

ROCKVILLE, MD, February 23, 2016 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that its President and Chief Executive […]

By |February 23rd, 2016|Recent News|

Therabron Therapeutics Makes Strategic Changes and Expands Management Team

ROCKVILLE, MD, December 10, 2015 — Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced new appointments and changes to the Company’s management […]

By |December 10th, 2015|Recent News|

Therabron Therapeutics Announces Favorable Infant Outcomes with Six-Month Follow-Up of a Phase 1b Recombinant Human CC10 Clinical Trial

ROCKVILLE, MD, December 8, 2015 — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to advancing a new standard in respiratory care, today presented a retrospective analysis of long-term follow-up data from […]

By |December 8th, 2015|Recent News|

Therabron Therapeutics Receives Accelerated Second Tranche from Series B Financing and Expands Investor Syndicate

ROCKVILLE, MD – November 9, 2015 – Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that the Company has received an accelerated […]

By |November 11th, 2015|Recent News|

Therabron Therapeutics to Participate in Upcoming Healthcare Conferences

ROCKVILLE, MD, October 15, 2015 – Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that it will participate in two […]

By |November 3rd, 2015|Recent News|

Therabron Therapeutics Reaches 50 Percent Enrollment in Phase 2 Clinical Trial for Lead Pediatric Respiratory Critical Care Program

ROCKVILLE, MD, July 21, 2015  — Therabron Therapeutics, Inc., a specialty biotechnology company dedicated to redefining the management of respiratory disease through innovation, today announced that it has achieved over […]

By |July 21st, 2015|Recent News|

Therabron Therapeutics Secures New Orphan Designation for the Prevention of Bronchopulmonary Dysplasia

ROCKVILLE, MD — May 13, 2015 — Therabron Therapeutics, Inc. (Therabron), a specialty biotechnology company focused on the advancement of respiratory therapeutics with disease-modifying potential, today announced that the European […]

By |May 13th, 2015|Recent News|

Therabron Therapeutics Names Thomas F. Miller President and Chief Operating Officer

ROCKVILLE, MD, May 7, 2015 — Therabron Therapeutics, Inc. (Therabron), a specialty biotechnology company focused on the advancement of respiratory therapeutics with disease-modifying potential, announced that it has named Thomas […]

By |May 7th, 2015|Recent News|

Therabron Therapeutics, Inc. Secures Up to $11M in Series B Financing

Rockville, MD. – December 17, 2014 – www.therabron.com a privately held clinical-stage biotechnology company, today announced that it has secured an investment of up to $11.1M in multiple tranches […]

By |December 17th, 2014|Recent News|

Clarassance is now Therabron Therapeutics

Rockville, MD. – December 12, 2014 – Clarassance, a privately held clinical-stage biotechnology company based in Maryland, today announced its new name: Therabron Therapeutics, Inc, which will serve it well […]

By |December 12th, 2014|Recent News|